Homozygous loss of mouse tetraspanin CD82 enhances integrin αIIbβ3 expression and clot retraction in platelets

Experimental Cell Research

Volumn 339, Issue 2, 2015, Pages 261-269

  Uchtmann, Kristen ^a   Park, Electa R ^a   Bergsma, Alexis ^a   Segula, Justin ^a   Edick, Mathew J ^a   Miranti, Cindy K ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Blood platelets; Cell adhesion; Disease model animals; Integrins; Tetraspanins

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA2BBETA3 INTEGRIN; CD82 ANTIGEN; COLLAGEN; INTEGRIN; PROTEIN TYROSINE KINASE; TETRASPANIN; TYROSINE; UNCLASSIFIED DRUG; FIBRINOGEN RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT RETRACTION; CONTROLLED STUDY; DEGRANULATION; FEMALE; GENETIC ENGINEERING; HOMOZYGOTE; HUMAN; HUMAN CELL; IN VIVO STUDY; KINETICS; MALE; MOUSE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; ANIMAL; DEFICIENCY; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; ANTIGENS, CD82; BLOOD PLATELETS; CLOT RETRACTION; HUMANS; MICE; MICE, KNOCKOUT; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 84973409581     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.11.006     Document Type: Article

References (38)

1. [1] Cimmino, G., Golino, P., Platelet biology and receptor pathways. J. Cardiovasc. Transl. Res. 6 (2013), 299–309.
2. [2] de Witt, S.M., Verdoold, R., Cosemans, J.M.E.M., Heemskerk, J.W.M., Insights into platelet-based control of coagulation. Thromb. Res. 133:2 (2014), S139–S148.
3. [3] Miranti, C., Bergsma, A., Van Spriel, A., Tetraspanins as master organizers of the plasma membrane., in: A.C.a.D. Lidke (Ed.), In Cell Membrane Nanodomains: from Biochemistry to Nanoscopy. 2014, CRC Press, Boca Raton, 59–86.
4. [4] Hemler, M.E., Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell. Dev. Biol. 19 (2003), 397–422.
5. [5] Haining, E.J., Yang, J., Tomlinson, M.G., Tetraspanin microdomains: fine-tuning platelet function. Biochem. Soc. Trans. 39 (2011), 518–523.
6. [6] Wright, M.D., Geary, S.M., Fitter, S., Moseley, G.W., Lau, L.M., Sheng, K.C., Apostolopoulos, V., Stanley, E.G., Jackson, D.E., Ashman, L.K., Characterization of mice lacking the tetraspanin superfamily member CD151. Mol. Cell. Biol. 24 (2004), 5978–5988.
7. [7] Goschnick, M.W., Lau, L.M., Wee, J.L., Liu, Y.S., Hogarth, P.M., Robb, L.M., Hickey, M.J., Wright, M.D., Jackson, D.E., Impaired “outside-in” integrin αIIbβ3 signaling and thrombus stability in TSSC6-deficient mice. Blood 108 (2006), 1911–1918.
8. [8] Lau, L.M., Wee, J.L., Wright, M.D., Moseley, G.W., Hogarth, P.M., Ashman, L.K., Jackson, D.E., The tetraspanin superfamily member CD151 regulates outside-in integrin αIIbβ3 signaling and platelet function. Blood 104 (2004), 2368–2375.
9. [9] Mangin, P.H., Kleitz, L., Boucheix, C., Gachet, C., Lanza, F., CD9 negatively regulates integrin αIIbβ3 activation and could thus prevent excessive platelet recruitment at sites of vascular injury. J. Thromb. Haemost. 7 (2009), 900–902.
10. [10] Schroder, J., Lullmann-Rauch, R., Himmerkus, N., Pleines, I., Nieswandt, B., Orinska, Z., Koch-Nolte, F., Schroder, B., Bleich, M., Saftig, P., Deficiency of the tetraspanin CD63 associated with kidney pathology but normal lysosomal function. Mol. Cell. Biol. 29 (2009), 1083–1094.
11. [11] Lewandrowski, U., Wortelkamp, S., Lohrig, K., Zahedi, R.P., Wolters, D.A., Walter, U., Sickmann, A., Platelet membrane proteomics: a novel repository for functional research. Blood 114 (2009), e10–e19.
12. [12] Protty, M.B., Watkins, N.A., Colombo, D., Thomas, S.G., Heath, V.L., Herbert, J.M., Bicknell, R., Senis, Y.A., Ashman, L.K., Berditchevski, F., Ouwehand, W.H., Watson, S.P., Tomlinson, M.G., Identification of Tspan9 as a novel platelet tetraspanin and the collagen receptor GPVI as a component of tetraspanin microdomains. Biochem. J. 417 (2009), 391–400.
13. [13] Odintsova, E., van Niel, G., Conjeaud, H., Raposo, G., Iwamoto, R., Mekada, E., Berditchevski, F., Metastasis Suppressor Tetraspanin CD82/KAI1 Regulates Ubiquitylation of Epidermal Growth Factor Receptor. J. Biol. Chem. 288 (2013), 26323–26334.
14. [14] He, B., Liu, L., Cook, G.A., Grgurevich, S., Jennings, L.K., Zhang, X.A., Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin α6-mediated cell adhesion. J. Biol. Chem. 280 (2005), 3346–3354.
15. [15] Han, S.Y., Lee, M., Hong, Y.K., Hwang, S., Choi, G., Suh, Y.S., Park, S.H., Lee, S., Lee, S.-H., Chung, J., Baek, S.H., Cho, K.S., Tsp66E, the Drosophila KAI1 homologue, and Tsp74F function to regulate ovarian follicle cell and wing development by stabilizing integrin localization. FEBS Lett. 586 (2012), 4031–4037.
16. [16] Sridhar, S.C., Miranti, C.K., Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Oncogene 25 (2006), 2367–2378.
17. [17] Odintsova, E., Sugiura, T., Berditchevski, F., Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr. Biol. 10 (2000), 1009–1012.
18. [18] Miranti, C.K., Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis. Cell. Signal 21 (2009), 196–211.
19. [19] Hall, B., Limaye, A., Kulkarni, A.B., Overview: generation of gene knockout mice. Curr. Protoc. Cell. Biol., 19, 2009 1 Chapter 19:Unit 19.12. p1-17.
20. [20] Su, H., Mills, A.A., Wang, X., Bradley, A., A targeted X-linked CMV-Cre line. Genesis 32 (2002), 187–188.
21. [21] Cannon, K.S., Cresswell, P., Quality control of transmembrane domain assembly in the tetraspanin CD82. EMBO J. 20 (2001), 2443–2453.
22. [22] Edick, M.J., Tesfay, L., Lamb, L.E., Knudsen, B.S., Miranti, C.K., Inhibition of integrin-mediated crosstalk with epidermal growth factor receptor/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase-independent death. Mol. Biol. Cell. 18 (2007), 2481–2490.
23. [23] Sachs, N., Kreft, M., van den Bergh Weerman, M.A., Beynon, A.J., Peters, T.A., Weening, J.J., Sonnenberg, A., Kidney failure in mice lacking the tetraspanin CD151. J. Cell. Biol. 175 (2006), 33–39.
24. [24] Custer, M.C., Risinger, J.I., Hoover, S., Simpson, R.M., Patterson, T., Barrett, J.C., Characterization of an antibody that can detect the Kai1/CD82 murine metastasis suppressor. Prostate 66 (2006), 567–577.
25. [25] Wang, H., Zhang, W., Zhao, J., Zhang, L., Liu, M., Yan, G., Yao, J., Yu, H., Yang, P., N-Glycosylation pattern of recombinant human CD82 (KAI1), a tumor-associated membrane protein. J. Proteom. 75 (2012), 1375–1385.
26. [26] Janes, S.L., Wilson, D.J., Cox, A.D., Chronos, N.A., Goodall, A.H., ADP causes partial degranulation of platelets in the absence of aggregation. Br. J. Haematol. 86 (1994), 568–573.
27. [27] Un-Jong Choi, B.-K.J.Y.L.K.-H.L., KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells. Cell. Biochem. Funct. 27 (2009), 40–47.
28. [28] Delaguillaumie, A., Lagaudriere-Gesbert, C., Popoff, M.R., Conjeaud, H., Rho GTPases link cytoskeletal rearrangements and activation processes induced via the tetraspanin CD82 in T lymphocytes. J. Cell. Sci. 115 (2002), 433–443.
29. [29] Lagaudriere-Gesbert, C., Lebel-Binay, S., Hubeau, C., Fradelizi, D., Conjeaud, H., Signaling through the tetraspanin CD82 triggers its association with the cytoskeleton leading to sustained morphological changes and T cell activation. Euro J. Immunol. 28 (1998), 4332–4344.
30. [30] Termini, C.M., Cotter, M.L., Marjon, K.D., Buranda, T., Lidke, K.A., Gillette, J.M., The membrane scaffold CD82 regulates cell adhesion by altering α4 integrin stability and molecular density. Mol. Biol. Cell. 25 (2014), 1560–1573.
31. [31] Wei, Q., Zhang, F., Richardson, M.M., Roy, N.H., Rodgers, W., Liu, Y., Zhao, W., Fu, C., Ding, Y., Huang, C., Chen, Y., Sun, Y., Ding, L., Hu, Y., Ma, J.X., Boulton, M.E., Pasula, S., Wren, J.D., Tanaka, S., Huang, X., Thali, M., Hammerling, G.J., Zhang, X.A., CD82 restrains pathological angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells. Circulation 130 (2014), 1493–1504.
32. [32] Morowski, M., Vogtle, T., Kraft, P., Kleinschnitz, C., Stoll, G., Nieswandt, B., Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice. Blood 121 (2013), 4938–4947.
33. [33] Wahlin, A., Risk of thrombosis in patients with myeloproliferative neoplasms and elevated platelet counts. Euro J. Haematol., 2015 http://dx.doi.org/10.1111/ejh.12585. [Epub ahead of print].
34. [34] Berditchevski, F., Odintsova, E., Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J. Cell. Biol. 146 (1999), 477–492.
35. [35] Iwata, S., Kobayashi, H., Miyake-Nishijima, R., Sasaki, T., Souta-Kuribara, A., Nori, M., Hosono, O., Kawasaki, H., Tanaka, H., Morimoto, C., Distinctive signaling pathways through CD82 and β1 integrins in human T cells, Euro. J. Immunol. 32 (2002), 1328–1337.
36. [36] Ruseva, Z., Geiger, P.X.C., Hutzler, P., Kotzsch, M., Luber, B., Schmitt, M., Gross, E., Reuning, U., Tumor suppressor KAI1 affects integrin αvβ3-mediated ovarian cancer cell adhesion, motility, and proliferation. Exp. Cell. Res. 315 (2009), 1759–1771.
37. [37] Spring, F.A., Griffiths, R.E., Mankelow, T.J., Agnew, C., Parsons, S.F., Chasis, J.A., Anstee, D.J., Tetraspanins CD81 and CD82 facilitate α4β1-mediated adhesion of human erythroblasts to vascular cell adhesion molecule-1. Plos One, 8, 2013, e62654.
38. [38] A.B. van Spriel, S. de Keijzer, A. van der Schaaf, K.H. Gartlan, M. Sofi, A. Light, P.C. Linssen, J.B. Boezeman, M. Zuidscherwoude, I. Reinieren-Beeren, A. Cambi, F. Mackay, D.M. Tarlinton, C.G. Figdor and M.D. Wright, The tetraspanin CD37 orchestrates the α4β1 integrin-Akt signaling axis and supports long-lived plasma cell survival, Sci. Signal. 5, 2012, pp. ra82.